Literature DB >> 20228400

Navigating the choices for diabetes prevention.

David M Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20228400     DOI： 10.1056/NEJMe1002322

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspective.

Authors:  Chris Degeling; Melanie Rock
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Advances in the treatment of prediabetes.

Authors:  Glenn Matfin; Richard E Pratley
Journal:  Ther Adv Endocrinol Metab       Date:  2010-02       Impact factor: 3.565

3.  Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.

Authors:  Laura J Gray; Jennifer R Tringham; Melanie J Davies; David R Webb; Janet Jarvis; Timothy C Skinner; Azhar M Farooqi; Kamlesh Khunti
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

4.  Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.

Authors:  Stefan Kiechl; Jürgen Wittmann; Andrea Giaccari; Michael Knoflach; Peter Willeit; Aline Bozec; Alexander R Moschen; Giovanna Muscogiuri; Gian Pio Sorice; Trayana Kireva; Monika Summerer; Stefan Wirtz; Julia Luther; Dirk Mielenz; Ulrike Billmeier; Georg Egger; Agnes Mayr; Friedrich Oberhollenzer; Florian Kronenberg; Michael Orthofer; Josef M Penninger; James B Meigs; Enzo Bonora; Herbert Tilg; Johann Willeit; Georg Schett
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

5.  Point: postprandial glucose levels are a clinically important treatment target.

Authors:  Antonio Ceriello
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

Review 6.  Differential pharmacology and benefit/risk of azilsartan compared to other sartans.

Authors:  Theodore W Kurtz; Takashi Kajiya
Journal:  Vasc Health Risk Manag       Date:  2012-02-28

7.  Effects of Acute Ingestion of Native Banana Starch on Glycemic Response Evaluated by Continuous Glucose Monitoring in Obese and Lean Subjects.

Authors:  Guadalupe Jiménez-Domínguez; Jorge L Ble-Castillo; María A Aparicio-Trápala; Isela E Juárez-Rojop; Carlos A Tovilla-Zárate; Deysi J Ble-Castillo; Carlos García-Vázquez; Viridiana Olvera-Hernández; Bedelia Pérez-Pimienta; Juan C Diaz-Zagoya; José D Mendez
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

8.  Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications.

Authors:  Zhongwen Zhang; Xiaoyun Wu; Tian Cai; Weiyi Gao; Xiaojun Zhou; Junyu Zhao; Jinming Yao; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Int J Environ Res Public Health       Date:  2015-07-14       Impact factor: 3.390

9.  Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.

Authors:  Luis A Vázquez; Ángel Rodríguez; Javier Salvador; Juan F Ascaso; Helmut Petto; Jesús Reviriego
Journal:  BMC Cardiovasc Disord       Date:  2014-11-01       Impact factor: 2.298

10.  Intracellular adhesion molecule-1 K469E gene polymorphism and risk of diabetic microvascular complications: a meta-analysis.

Authors:  Xianghui Su; Xi Chen; Lei Liu; Xiangyun Chang; Xuefeng Yu; Kan Sun
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.